ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,322Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 680

$1.15M Total Retail Price of All Prescriptions

Rank: 54 out of 680

638 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 638 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

9% of this provider’s 638 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 11,830 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
METFORMIN HCL ER 593 442 1 54
LEVOTHYROXINE SODIUM 585 480 2 2
ATORVASTATIN CALCIUM 528 374 3 11
AMLODIPINE BESYLATE 504 402 4 1
LOSARTAN POTASSIUM 480 359 5 21
SIMVASTATIN 448 362 6 3
OMEPRAZOLE 408 342 7 7
CRESTOR 377 330 8 25
HYDROCHLOROTHIAZIDE 362 278 9 9
LISINOPRIL 322 231 10 5
METOPROLOL SUCCINATE 301 243 11 13
FUROSEMIDE 294 181 12 6
PRAVASTATIN SODIUM 277 230 13 10
GABAPENTIN 248 191 14 15
NEXIUM 231 111 15 16
ZOLPIDEM TARTRATE 215 147 16 17
SERTRALINE HCL 215 144 16 28
FENOFIBRATE 193 145 18 66
FLUTICASONE PROPIONATE 186 139 19 41
ALLOPURINOL 183 138 20 33
DIOVAN 179 160 21 31
METOPROLOL TARTRATE 176 127 22 12
HYDROCODONE-ACETAMINOPHEN 174 96 S3 23 4
TRAMADOL HCL 174 99 23 18
GLIMEPIRIDE 172 141 25 29
METFORMIN HCL 154 117 26 8
ATENOLOL 149 118 27 19
CITALOPRAM HBR 148 103 28 22
JANUVIA 141 92 29 60
LANTUS SOLOSTAR 140 88 30 84
PEN NEEDLE 139 86 31 122
LISINOPRIL-HYDROCHLOROTHIAZIDE 133 98 32 37
HYDRALAZINE HCL 132 96 33 71
PANTOPRAZOLE SODIUM 125 75 34 30
LOSARTAN-HYDROCHLOROTHIAZIDE 124 94 35 51
SYNTHROID 124 103 35 38
CLOPIDOGREL 124 104 35 26
ZETIA 122 88 38 87
PLAVIX 122 112 38 39
WARFARIN SODIUM 117 83 40 20
POTASSIUM CHLORIDE 115 77 41 14
LIPITOR 110 75 42 68
CARVEDILOL 107 82 43 23
CYMBALTA 104 83 44 46
TAMSULOSIN HCL 93 68 45 34
INSULIN SYRINGE 91 59 46 86
TRAZODONE HCL 88 50 47 48
FAMOTIDINE 87 60 48 89
DIOVAN HCT 86 68 49 55
KLOR-CON M20 85 56 50 61
ONGLYZA 84 61 51 136
DONEPEZIL HCL 83 83 52 27
LANTUS 83 58 52 49
FLUOXETINE HCL 81 36 54 74
SPIRONOLACTONE 78 53 55 82
ADVAIR DISKUS 73 34 56 53
ACTOS 72 67 57 114
CEFDINIR 71 43 58 212
PAROXETINE HCL 71 52 58 76
AMLODIPINE BESYLATE-BENAZEPRIL 68 66 60 43
MELOXICAM 66 50 61 24
LUNESTA 64 28 62 252
BYSTOLIC 61 44 63 79
ESCITALOPRAM OXALATE 59 46 64 45
VENLAFAXINE HCL ER 58 47 65 101
BUPROPION XL 57 29 66 161
CLONIDINE HCL 55 31 67 36
LORAZEPAM 54 51 68 125
CIPROFLOXACIN HCL 52 37 69 57
HUMALOG 51 29 70 196
AMOXICILLIN 51 31 70 111
BENAZEPRIL HCL 50 46 72 40
ALPRAZOLAM 50 23 72 72
RANITIDINE HCL 50 50 72 56
NAMENDA 50 50 72 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.